Bristol-Myers Joins Big Pharma Attack On Price Negotiating
Bristol-Myers Squibb Co. on Friday lobbed yet another challenge to landmark legislation allowing Medicare to negotiate drug prices, slamming the law as unconstitutional and not actually involving negotiations "in any ordinary...To view the full article, register now.
Already a subscriber? Click here to view full article